UICC World Cancer Congress 2006

Methods:Use the author's knowledge,designed a strategy for a new early diagnosing cancers method.

Results:Using two different anti-Rb normal protein antibodies and anti-p53 normal protein antibodies respectively , through Affinitive Chromatography , develops antigens and antibodies immune reactions respectively , with radioisotope atoms labeled pathological specimen Rb proteins and p53 . Then respectively tests the radioactive intensity of radioisotope atoms labeled Rb proteins and p53 just taking place the immune reactions . According to these experiments , can judge if the structures and functions of Rb genes and proteins and p53 genes and proteins are normal or abnormal . So can diagnose early the cancer . Here is the judgement: If the intensity of II- antibody by the radio - activity immune reaction is lower than the intensity of radio-activity by the I- antibody's immune reaction or there is no intensity of radio-activity by the II- antibody's immune reaction . The author can say that this patient of specimen has the abnormalities of functions and structures of Rb and p53 proteins . So the related Rb and p53 genes are almost also abnormal . So on to judge other conditions. Conclusions : This strategy for a new early diagnosing cancers is worth to be further researched and applied to clinical practice and prevention . And invent and uses a new molecular biology research method .